The Vizient Summer 2025 Spend Management Outlook (SMO) provides an integrated perspective on trends, factors and future expenses providers will face across the various dimensions of healthcare. In this episode, Dr. Carina Dolan and Dr. Jeni Hayes join host Carolyn Liptak to discuss pharmacy insights from the SMO including declining drug price inflation and how autoimmune conditions have surpassed oncology in total pharmacy costs. They also touch on pediatric spend drivers, biosimilar competition, and the impact of novel therapies. Tune in to VerifiedRx for practical insights to help pharmacy leaders plan for what’s ahead.
 
Guest speakers: 
Carina Dolan, Pharm. D., MS Pharm, BCOP  
Associate Vice President, Clinical Oncology, Pharmacoeconomics and Market Insights  
Vizient 
 
Jeni Hayes, PharmD, MS Pharm, BCPS 
Senior Clinical Manager, Market Intelligence 
Vizient  
 
Host:  
Carolyn Liptak, BS Pharm, MBA 
VerifiedRx Host 
 
Show Notes: 
[01:13-02:41]  Key pharmacy trends emerging from the Summer SMO
[02:42-04:00] Current pharmacy trends
[04:01-05:55]  Pharmacy spend for autoimmune conditions has exceeded that of oncology
[05:56-07:36] Key takeaways
[07:37-08:47] Significant trends in this latest therapeutic insights update
[08:48-10:04] Challenges in gene and cell therapy space
[10:05-11:33] The Therapeutic Insights webpage for pediatrics
[11:34-13:41] Other reflections from the SMO
[13:42-14:49]  How to locate the SMO
 
Links | Resources: 
Vizient Spend Management Outlook
Vizient Therapeutic class insights
 
VerifiedRx Listener Feedback Survey:
We would love to hear from you - Please click here
 
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Spotify
Android
RSS Feed

Ver todos los episodios